Quarterly report pursuant to Section 13 or 15(d)

Stock-based compensation - Stock option activity (Details)

v3.21.2
Stock-based compensation - Stock option activity (Details) - Stock Options - USD ($)
$ / shares in Units, $ in Thousands
5 Months Ended 9 Months Ended
Jun. 11, 2021
Oct. 31, 2021
Oct. 31, 2021
Shares      
Granted (in shares)   2,825,752  
Outstanding at end period (in shares)   2,825,752 2,825,752
Weighted Average Exercise Price      
Weighted Average Exercise Price Granted (in dollars per share)   $ 10.76  
Weighted Average Exercise Price Outstanding at end period (in dollars per share)   $ 10.76 $ 10.76
Weighted Average Remaining Contractual Term (Years)      
Weighted Average Remaining Contractual Term Outstanding (in Years) 9 years 8 months 12 days 9 years 8 months 12 days  
Aggregate Intrinsic Value      
Aggregate Intrinsic Value Outstanding   $ 3,872 $ 3,872
Unrecognized equity-based compensation costs   $ 8,700 $ 8,700
Cost expected to be recognized over a weighted-average period     3 years 8 months 12 days